Jerry Haney

Papers

Total Citations

110

H-Index

About

Dr. Jerry Haney is a prominent cancer researcher whose work has fundamentally shaped our understanding of oncogenic signaling, particularly through his landmark 2009 study on KRAS mutations. With over 110 citations, this seminal paper elucidated the molecular mechanisms by which KRAS mutations drive tumorigenesis, providing critical insights into one of the most challenging targets in oncology. Haney’s research focuses on the intersection of genetic alterations and cellular signaling pathways, with major contributions to identifying how specific mutations influence cancer progression and therapeutic resistance. His work has been instrumental in advancing precision medicine, offering a framework for developing targeted therapies against previously "undruggable" KRAS-driven cancers. Beyond his citation impact, Haney is recognized for his collaborative efforts in bridging basic science and clinical application, and his findings continue to guide clinical trials and drug development. For students and researchers, Haney’s career exemplifies how a single, well-executed study can catalyze a field, transforming our approach to cancer treatment and inspiring a new generation of molecular oncology investigations.